GB0709489A
GB0709489D0
(en)
|
2007-05-17 |
2007-05-17 |
New use
|
PL08750626T
PL2182950T3
(en)
|
2007-05-17 |
2008-05-16 |
Use of 4-(pyrrolidin-1-yl)quinoline compounds to kill clinically latent microorganisms
|
JP2010507981A
JP5474768B2
(en)
|
2007-05-17 |
2008-05-16 |
Use of 4- (pyrrolidin-1-yl) quinoline compounds for killing clinically latent microorganisms
|
EP08750626.7A
EP2182950B8
(en)
|
2007-05-17 |
2008-05-16 |
Use of 4-(pyrrolidin-1-yl)quinoline compounds to kill clinically latent microorganisms
|
RU2009146828/15A
RU2520766C2
(en)
|
2007-05-17 |
2008-05-16 |
Application of 4-(pyrrolidine-1-yl)quinoline compounds for elimination of clinically latent microorganisms
|
CN200880016456.XA
CN101795688B
(en)
|
2007-05-17 |
2008-05-16 |
Use of 4-(pyrrolidin-1-yl)quinoline compounds to kill clinically latent microorganisms
|
ES08750626.7T
ES2637999T3
(en)
|
2007-05-17 |
2008-05-16 |
Use of 4- (pyrrolidin-1-yl) quinoline compounds to eliminate clinically latent microorganisms
|
CA2684692A
CA2684692C
(en)
|
2007-05-17 |
2008-05-16 |
Use of 4-(pyrrolidin-1-yl)quinoline compounds to kill clinically latent microorganisms
|
MX2009012390A
MX2009012390A
(en)
|
2007-05-17 |
2008-05-16 |
Use of 4-(pyrrolidin-1-yl)quinoline compounds to kill clinically latent microorganisms.
|
PT87506267T
PT2182950T
(en)
|
2007-05-17 |
2008-05-16 |
Use of 4-(pyrrolidin-1-yl)quinoline compounds to kill clinically latent microorganisms
|
BRPI0811745-4A
BRPI0811745B1
(en)
|
2007-05-17 |
2008-05-16 |
COMPOUNDS OF 4- (PYRROLIDIN-1-IL) QUINOLINE, USE AND PROCESS FOR THE PREPARATION OF THE SAME, PHARMACEUTICAL FORMULATION -
|
AU2008252636A
AU2008252636B2
(en)
|
2007-05-17 |
2008-05-16 |
Use of 4-(pyrrolidin-1-yl)quinoline compounds to kill clinically latent microorganisms
|
SI200831883T
SI2182950T1
(en)
|
2007-05-17 |
2008-05-16 |
Use of 4-(pyrrolidin-1-yl)quinoline compounds to kill clinically latent microorganisms
|
DK08750626.7T
DK2182950T3
(en)
|
2007-05-17 |
2008-05-16 |
USE OF 4- (PYRROLIDIN-1-YL) QUINOLINE COMPOUNDS TO KILL CLINIC LATENT MICROORGANISMS
|
KR1020097026394A
KR101599384B1
(en)
|
2007-05-17 |
2008-05-16 |
The use of 4 (pyrrolidine 1 day) quinoline compounds to clinically kill latent microorganisms
|
US12/600,470
US8759348B2
(en)
|
2007-05-17 |
2008-05-16 |
Use of 4-(pyrrolidin-1-yl)quinoline compounds to kill clinically latent microorganisms
|
PCT/GB2008/001694
WO2008142384A1
(en)
|
2007-05-17 |
2008-05-16 |
Use of 4-(pyrrolidin-1-yl)quinoline compounds to kill clinically latent microorganisms
|
HUE08750626A
HUE034298T2
(en)
|
2007-05-17 |
2008-05-16 |
Use of 4-(pyrrolidin-1-yl)quinoline compounds to kill clinically latent microorganisms
|
NZ580625A
NZ580625A
(en)
|
2007-05-17 |
2008-05-16 |
Use of 4-(pyrrolidin-1-yl)quinoline compounds to kill clinically latent microorganisms
|
IL201392A
IL201392A
(en)
|
2007-05-17 |
2009-10-11 |
Use of 4 -pyrrolidin-1- yl) quinoline compounds for the production of medicaments for killing clinically latent microorganisms
|
HRP20171553TT
HRP20171553T1
(en)
|
2007-05-17 |
2017-10-13 |
Use of 4-(pyrrolidin-1-yl)quinoline compounds to kill clinically latent microorganisms
|